文献速递呼吸衰竭与机械通气复苏、休克与脓毒症重症综合管理与镇静镇痛

鹦鹉热衣原体感染肺炎患者的临床特征分析

[Clinical characteristics analysis of patients with pneumonia infected by Chlamydia psittaci].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论鹦鹉热衣原体肺炎可快速进展为重症ARDS和休克,早期mNGS确诊及喹诺酮/四环素类治疗可改善预后。

该研究回顾性分析3例鹦鹉热衣原体肺炎患者,均有宠物或人畜接触史,表现为高热、咳嗽、胸闷、呼吸困难,快速进展为重症ARDS和休克,但心肝肾损伤较轻。实验室示CRP>200 mg/L、中性粒细胞比例>0.90,而WBC和PCT无明显升高;胸部CT示间质改变伴炎性浸润。mNGS确诊后,经喹诺酮或四环素类治疗2-3天体温降至正常,10天后拔管转普通病房,总病程20-30天。

要点

  • 3例均有宠物或人畜接触史,表现为高热(>39℃)、咳嗽、胸闷、呼吸困难,快速进展为重症ARDS和休克。
  • 实验室特征:CRP均>200 mg/L、中性粒细胞比例>0.90,但WBC和PCT无明显升高,心肝肾损伤较轻。
  • 胸部CT示间质改变伴炎性浸润(单侧或双侧);胸片示大片炎性浸润,呈扇形或楔形至胸膜边缘。
  • mNGS证实痰中鹦鹉热衣原体,对喹诺酮类和四环素类敏感;抗生素治疗2-3天体温降至正常。
  • 治疗7天床旁X线示浸润吸收,11-13天CT复查基本吸收;10天后拔管转普通病房,总病程20-30天。

适用人群与场景

  • 回顾性分析3例鹦鹉热衣原体肺炎患者,均有宠物或人畜接触史,来自急诊/ICU住院人群。

诊断标准与关键阈值

  • 诊断依赖mNGS证实痰中鹦鹉热衣原体;临床特征包括高热(>39℃)、咳嗽、咳痰、胸闷、呼吸困难,快速进展为重症ARDS和休克;CRP>200 mg/L、中性粒细胞比例>0.90,WBC和PCT无明显升高。

处置流程与药物剂量

  • 第一步:对有宠物或人畜接触史、高热、呼吸道症状及快速进展为ARDS/休克者,尽早行mNGS检测。
  • 第二步:确诊后选用喹诺酮类或四环素类抗生素(原文未提及具体药物、剂量、途径及疗程)。
  • 第三步:抗生素治疗2-3天体温降至正常,7天床旁X线示浸润吸收,11-13天CT复查基本吸收,10天后拔管转普通病房。

红旗征与不能漏的情况

  • 快速进展为重症ARDS和休克,需立即按重症ARDS和休克处理(原文未提及具体处理措施)。

研究设计与关键结果

  • 回顾性分析3例鹦鹉热衣原体肺炎患者,均有宠物或人畜接触史;全部表现为高热(>39℃)、咳嗽、咳痰、胸闷、呼吸困难,快速进展为重症ARDS和休克,心肝肾损伤较轻;CRP均>200 mg/L、中性粒细胞比例>0.90,WBC和PCT无明显升高;mNGS确诊,对喹诺酮类和四环素类敏感;抗生素治疗2-3天体温正常,10天后拔管转病房,总病程20-30天。

证据类型、等级与局限

  • 回顾性病例分析(3例),样本量小,单中心,无对照,证据等级低;原文未提及证据等级或推荐强度。

对床旁实践的改变

  • 对急诊/ICU中快速进展为重症ARDS和休克、CRP显著升高但PCT不高的肺炎患者,尤其有宠物或人畜接触史者,应怀疑鹦鹉热衣原体肺炎并尽早行mNGS检测;确诊后选用喹诺酮类或四环素类抗生素(原文未提及具体方案)可改善预后。不适用于无接触史或非典型病原体感染者;常见陷阱为因PCT不高而低估病情严重程度。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To explore the clinical characteristics of pneumonia infected by Chlamydophila psittaci (C. psittaci).

METHODS: A retrospective analysis was performed on 3 cases of C. psittaci pneumonia admitted to People's Hospital of Tongling City from July 2019 to January 2020. The patients' contact history, clinical manifestations, laboratory examination, imaging characteristics and evolution, etiology, treatment process and outcome were analyzed, so as to provide experience for the diagnosis and prevention of C. psittaci pneumonia.

RESULTS: The 3 patients had been infected through pet or zoonotic exposures. All symptoms included high fever (body temperature > 39 centigrade), cough, sputum, chest tightness and dyspnea. The disease progressed rapidly, with severe acute respiratory distress syndrome (ARDS) and shock as the main manifestations, but the damages to the heart, liver and kidney were mild. Laboratory tests showed that C-reactive protein (CRP, all > 200 mg/L) and neutrophil proportion (Neut%, > 0.90) were significantly increased, while white blood cell count (WBC) and procalcitonin (PCT) were not significantly increased. Chest computed tomography (CT) showed inflammatory infiltration with interstitial changes, either unilateral or bilateral. Chest X-ray showed large areas of inflammatory infiltrations, fan-shaped or wedge-shaped to the edge of pleura. After 7 days of treatment, the bedside computed X-ray (CR) showed absorption of infiltration. After 11-13 days, the CT reexamination indicated lung infection was basically absorbed. Metagenomic next-generation sequencing (mNGS) confirmed the presence of C. psittaci in patients' sputum. It was sensitive to quinolones and tetracyclines. The patients' body temperature dropped to normal after 2-3 days of antibiotics, and all patients were extubated and transferred to normal ward 10 days later. The total course of illness was 20-30 days.

CONCLUSIONS: The patients with C. psittaci pneumonia are critically ill, and clinical manifestations of moderate to severe ARDS and shock are common. Early diagnosis depends on mNGS, and reasonable treatment is important for prognosis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wang Y, Lu H, Shao R, et al. [Clinical characteristics analysis of patients with pneumonia infected by Chlamydia psittaci]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33463503. doi:10.3760/cma.j.cn121430-20200408-00259

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。